Macular Disease Foundation Australia logo

    Research news

    Research News

    The latest funding round now brings MDFA’s commitment to macular disease research to $7.2 million across 44 projects since 2011.

    Read more

    Most recent

    2025 Research Grant Recipient

    Reducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis

    2025 Research Grant Recipient

    Towards a personalised approach to predicting and preventing progression of age-related macular degeneration

    2025 Research Grant Recipient 

    Genotype-phenotype correlations in PRPH2-associated retinal dystrophy

    2025 Research Grant Recipient  

    Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration

    2025 Grant Family Fund Award Recipient

    Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies

    2025 Grant Family Fund Award Recipient

    Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision

    $1 million investment in new macular disease research 

    MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.

    MDFA invests $1 million into macular disease research

    Macular Disease Foundation Australia today announced it has awarded more than $1 million to eight

    MDFA launches $200,000 grant for geographic atrophy research

    Macular Disease Foundation Australia (MDFA) has announced the launch of its inaugural MDFA 25th Anniversary Award

    Loading...